ADDvise Group AB (publ) ("ADDvise Group") has initiated the process of listing the company's A and B shares on Nasdaq Stockholm. The change of listing venue is expected to be completed in the first quarter of 2025.
As part of the continued development of ADDvise Group, the company has for some time reviewed the possibility of changing its listing venue from Nasdaq First North to Nasdaq Stockholm main market. The Board of Directors believes that a change of listing venue would be beneficial for the company's continued development, provide a broader capital allocation toolkit, and increase the company’s attractiveness to institutional investors. The Board of Directors and management have therefore initiated the process to change listing venue.
"We believe that ADDvise Group is ready to be listed on Nasdaq Stockholm main market. An uplisting is a stamp of quality and a natural next step in the company’s development. Among other things, the change of listing venue would open up the possibility to buy back own shares, which is an important instrument in optimising our capital allocation" says Rikard Akhtarzand, CEO of ADDvise Group.
ADDvise Group’s A and B shares have been listed on Nasdaq First North since 1998 and 2015 respectively. The change of listing venue to Nasdaq Stockholm is intended to take place without an offering or other sale of ADDvise Group's shares.
Further information will be provided closer to the time of uplisting.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 (0) 76-525 90 71
rikard.akhtarzand@addvisegroup.se
Oliver Humlen, CFO
+46 (0) 70-916 26 97
oliver.humlen@addvisegroup.se
Important information
This information is such that ADDvise Group AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons above, on May 7, 2024, at 08:30 CEST.
About ADDvise
ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.